SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-277564
Filing Date
2023-11-15
Accepted
2023-11-15 08:42:29
Documents
14
Period of Report
2023-11-10
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d882839d8k.htm   iXBRL 8-K 32406
2 EX-10.1 d882839dex101.htm EX-10.1 51042
6 GRAPHIC g882839g1115084411573.jpg GRAPHIC 3141
  Complete submission text file 0001193125-23-277564.txt   228532

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA maia-20231110.xsd EX-101.SCH 2509
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20231110_lab.xml EX-101.LAB 17947
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20231110_pre.xml EX-101.PRE 11234
8 EXTRACTED XBRL INSTANCE DOCUMENT d882839d8k_htm.xml XML 3536
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 231409156
SIC: 2834 Pharmaceutical Preparations